the recommendation is conditional because all members acknowledged that short-term glucocorticoids are frequently necessary to alleviate symptoms prior to the onset of action of DMARDs. Treatment with glucocorticoids should be limited to the lowest effective dose for the shortest duration possible. The toxicity associated with glucocorticoids was judged to outweigh potential benefits. Initiation of a csDMARD without longerterm (â‰¥3 months) glucocorticoids is strongly recommended over initiation